First Trust Advisors LP Sells 962 Shares of The Cigna Group (NYSE:CI)

First Trust Advisors LP lowered its position in The Cigna Group (NYSE:CI - Free Report) by 1.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 80,488 shares of the health services provider's stock after selling 962 shares during the period. First Trust Advisors LP's holdings in The Cigna Group were worth $22,226,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CI. Kesler Norman & Wride LLC increased its position in The Cigna Group by 1.8% during the 4th quarter. Kesler Norman & Wride LLC now owns 2,033 shares of the health services provider's stock valued at $562,000 after buying an additional 35 shares in the last quarter. Hudson Edge Investment Partners Inc. increased its position in The Cigna Group by 1.9% during the 4th quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider's stock valued at $520,000 after buying an additional 36 shares in the last quarter. Meridian Wealth Management LLC increased its position in The Cigna Group by 1.0% during the 4th quarter. Meridian Wealth Management LLC now owns 3,670 shares of the health services provider's stock valued at $1,013,000 after buying an additional 37 shares in the last quarter. Mindset Wealth Management LLC increased its position in The Cigna Group by 2.6% during the 4th quarter. Mindset Wealth Management LLC now owns 1,469 shares of the health services provider's stock valued at $406,000 after buying an additional 37 shares in the last quarter. Finally, Jacobi Capital Management LLC increased its position in The Cigna Group by 2.2% during the 4th quarter. Jacobi Capital Management LLC now owns 1,749 shares of the health services provider's stock valued at $483,000 after buying an additional 38 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

The Cigna Group Stock Performance

NYSE CI traded up $2.43 on Tuesday, hitting $337.25. 1,272,144 shares of the company traded hands, compared to its average volume of 1,700,526. The company has a market capitalization of $92.30 billion, a price-to-earnings ratio of 27.55, a P/E/G ratio of 0.98 and a beta of 0.51. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The business's 50 day moving average price is $320.58 and its 200-day moving average price is $310.05. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the previous year, the company earned $6.79 EPS. Equities analysts expect that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be issued a dividend of $1.51 per share. The ex-dividend date is Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a yield of 1.79%. The Cigna Group's dividend payout ratio is presently 49.35%.

Analyst Ratings Changes

A number of research analysts recently weighed in on CI shares. Raymond James reaffirmed a "strong-buy" rating and set a $360.00 price objective (down previously from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. StockNews.com raised The Cigna Group from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, April 8th. Sanford C. Bernstein downgraded The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 target price on the stock. in a research note on Thursday, February 6th. Mizuho increased their target price on The Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Finally, Stephens cut their target price on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a research note on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat.com, The Cigna Group presently has a consensus rating of "Buy" and a consensus price target of $373.56.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, insider Noelle K. Eder sold 9,944 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $320.00, for a total transaction of $3,182,080.00. Following the sale, the insider now directly owns 13,406 shares of the company's stock, valued at $4,289,920. This trade represents a 42.59 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elder Granger sold 2,376 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the sale, the director now directly owns 5,471 shares in the company, valued at approximately $1,697,924.85. This represents a 30.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,751 shares of company stock valued at $13,603,991 over the last ninety days. 0.70% of the stock is currently owned by company insiders.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.